G
Guangzhou LBP Medicine Science & Technology Co Ltd
SSE:688393
Guangzhou LBP Medicine Science & Technology Co Ltd
SSE:688393
Price:
27.84
CNY
-0.82%
Market Closed
Market Cap:
¥2.6B
Balance Sheet
Balance Sheet Decomposition
Guangzhou LBP Medicine Science & Technology Co Ltd
Guangzhou LBP Medicine Science & Technology Co Ltd
Balance Sheet Decomposition is not available for
Guangzhou LBP Medicine Science & Technology Co Ltd
Guangzhou LBP Medicine Science & Technology Co Ltd
Balance Sheet
Guangzhou LBP Medicine Science & Technology Co Ltd
Guangzhou LBP Medicine Science & Technology Co Ltd
Currency: CNY
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
74
|
75
|
86
|
635
|
218
|
90
|
68
|
93
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
90
|
68
|
93
|
|
| Cash Equivalents |
74
|
75
|
86
|
635
|
218
|
0
|
0
|
0
|
|
| Short-Term Investments |
59
|
57
|
85
|
211
|
419
|
176
|
53
|
55
|
|
| Total Receivables |
153
|
170
|
172
|
189
|
221
|
250
|
255
|
252
|
|
| Accounts Receivables |
148
|
164
|
169
|
185
|
209
|
236
|
236
|
241
|
|
| Other Receivables |
5
|
6
|
2
|
4
|
12
|
14
|
19
|
11
|
|
| Inventory |
19
|
24
|
21
|
25
|
41
|
63
|
75
|
84
|
|
| Other Current Assets |
2
|
3
|
3
|
3
|
11
|
16
|
117
|
207
|
|
| Total Current Assets |
307
|
329
|
366
|
1 063
|
909
|
595
|
568
|
692
|
|
| PP&E Net |
80
|
111
|
134
|
194
|
277
|
327
|
314
|
299
|
|
| PP&E Gross |
80
|
111
|
134
|
194
|
277
|
327
|
314
|
299
|
|
| Accumulated Depreciation |
43
|
49
|
56
|
61
|
75
|
78
|
106
|
135
|
|
| Intangible Assets |
7
|
6
|
6
|
6
|
6
|
7
|
23
|
33
|
|
| Goodwill |
6
|
8
|
8
|
8
|
30
|
30
|
26
|
26
|
|
| Long-Term Investments |
0
|
8
|
8
|
8
|
66
|
396
|
423
|
262
|
|
| Other Long-Term Assets |
12
|
15
|
17
|
14
|
79
|
38
|
46
|
51
|
|
| Other Assets |
6
|
8
|
8
|
8
|
30
|
30
|
26
|
26
|
|
| Total Assets |
412
N/A
|
477
+16%
|
538
+13%
|
1 292
+140%
|
1 366
+6%
|
1 393
+2%
|
1 400
+1%
|
1 363
-3%
|
|
| Liabilities | |||||||||
| Accounts Payable |
14
|
29
|
31
|
56
|
50
|
33
|
37
|
33
|
|
| Accrued Liabilities |
11
|
12
|
15
|
18
|
27
|
36
|
32
|
31
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
7
|
14
|
21
|
7
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
3
|
3
|
2
|
1
|
|
| Other Current Liabilities |
10
|
14
|
11
|
14
|
21
|
28
|
18
|
12
|
|
| Total Current Liabilities |
35
|
55
|
58
|
87
|
107
|
114
|
110
|
85
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
3
|
7
|
5
|
2
|
|
| Deferred Income Tax |
0
|
3
|
6
|
7
|
13
|
16
|
14
|
13
|
|
| Minority Interest |
4
|
3
|
1
|
0
|
6
|
2
|
21
|
20
|
|
| Other Liabilities |
30
|
30
|
30
|
30
|
33
|
29
|
28
|
28
|
|
| Total Liabilities |
69
N/A
|
90
+30%
|
95
+5%
|
124
+31%
|
162
+30%
|
164
+2%
|
136
-17%
|
107
-21%
|
|
| Equity | |||||||||
| Common Stock |
70
|
70
|
70
|
93
|
93
|
93
|
94
|
94
|
|
| Retained Earnings |
138
|
182
|
238
|
323
|
377
|
394
|
421
|
428
|
|
| Additional Paid In Capital |
135
|
135
|
135
|
752
|
734
|
741
|
749
|
734
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
343
N/A
|
387
+13%
|
443
+15%
|
1 168
+163%
|
1 204
+3%
|
1 229
+2%
|
1 264
+3%
|
1 256
-1%
|
|
| Total Liabilities & Equity |
412
N/A
|
477
+16%
|
538
+13%
|
1 292
+140%
|
1 366
+6%
|
1 393
+2%
|
1 400
+1%
|
1 363
-3%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
70
|
70
|
70
|
93
|
93
|
93
|
94
|
94
|
|
Switch to:
Switch to:
See Also
Discover More
